全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

WAS基因缺陷小鼠巨细胞病毒急性感染模型的建立及感染特点

, PP. 2065-2070

Keywords: 鼠巨细胞病毒,WAS基因缺陷小鼠,感染模型,流式细胞术

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的用小鼠巨细胞病毒(murinecytomegalovirus,MCMV)Smith株建立WAS基因缺陷小鼠(129S6/SvEvTac-Wastm1Sbs/J)全身播散型感染模型并观察感染特点。方法同窝内简单随机法选取实验组小鼠(129S6/SvEvTac)WASp-/-(雌雄各半),感染对照组小鼠(129S1/SvImNJ)WASp+/+6只,雌雄各半,6~8周龄。腹腔内接种0.2mL小鼠巨细胞病毒悬液1×105PFU;另设6只129S6小鼠为空白对照组。各组分别接种MCMV9d后处死小鼠,取小鼠唾液腺分离病毒,RT-PCR检测小鼠主要脏器组织中MCMVgB基因,HE病理染色观察小鼠脏器病理损害,流式细胞术检测WAS基因缺陷小鼠脾脏MCMV特异性细胞毒性T细胞(CTL)比例。结果与对照组野生型小鼠相比,实验组WASp-/-小鼠MCMV感染后一般状况差,体质量下降,活动少,耸毛反应明显,有死亡(1/6)。感染后第9天,实验组和感染对照组小鼠唾液腺均分离出巨细胞病毒,主要脏器心、肝、肺、肾和唾液腺中MCMVgB基因RT-PCR检测结果为阳性。实验组小鼠肺内MCMVgB基因mRNA含量显著高于对照组小鼠(P<0.05),空白对照组未检测出病毒。MCMV感染后主要脏器出现明显病理损害,其中肺部病理损害严重。流式细胞术检测结果显示WAS基因缺陷小鼠脾脏MCMVCTL比率与对照组比较无统计学差异(P=0.26)。结论腹腔注射MCMV1×105PFU成功建立成年WAS基因缺陷小鼠急性感染模型,观察到较对照组野生型小鼠更明显的、较重的急性感染反应;肺为感染主要靶器官之一;初次感染后脾脏MCMVCTL比例无明显变化。

References

[1]  赵晓东. Wiskott-Aldrich 综合征研究进展[J]. 实用儿科临床杂志,? 2012,? 27(21):? 1621-1624. [2]于洁,? 管贤敏,? 戴碧涛,? 等. 造血干细胞移植治疗Wiskott-Aldrich综合征一例报告及文献复习[J]. 中华儿科杂志,? 2009,? 47(3):? 183-188. [3]Kaneko M,? Watanabe T,? Watanabe H,? et al. Successful unrelated cord blood transplantation in an infant with Wiskott-Aldrich syndrome following recurrent cytomegalovirus disease[J]. Int J Hematol,? 2003,? 78(5):? 457-460. [4]殷震, 刘景华. 动物病毒学[W].北京: 科学出版社,? 1997:? 614. [5]刘兴楼,? 舒赛男,? 王慧,? 等. 鼠巨细胞病毒感染小鼠感染性病毒滴度和基因表达的研究[J]. 临床儿科杂志,? 2011,? 29(4):? 363-366. [6]罗小华,? 常英军,? 霍明瑞,? 等. 同胞HLA全相合骨髓和外周血造血干细胞混合移植后血液病患者CMV特异性T细胞免疫重建规律[J]. 中华血液学杂志,? 2012,? 33(8):? 605-609. [7]Luo X H,? Huang X J,? Liu K Y,? et al. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts:? its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant,? 2010,? 16(7):? 994-1004. [8]Snapper S B,? Rosen F S,? Mizoguchi E,? et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation[J]. Immunity,? 1998,? 9(1):? 81-91. [9]Chong K T,? Mims C A. Murine cytomegalovirus particle types in relation to sources of virus and pathogenicity[J]. J Gen Virol,? 1981,? 57(Pt 2):? 415-419. [10]Krmpotic A,? Bubic I,? Polic B,? et al. Pathogenesis of murine cytomegalovirus infection[J]. Microbes Infect,? 2003,? 5(13):? 1263-1277. [11]Westerberg L S,? Dahlberg C,? Baptista M,? et al. Wiskott-Aldrich syndrome protein (WASP) and N-WASP are critical for peripheral B-cell development and function[J]. Blood,? 2012,? 119(17):? 3966-3974. [12]Banks T A,? Rouse B T. Herpesviruses--immune escape artists?[J]. Clin Infect Dis,? 1992,? 14(4):? 933-941. [13]Reddehase M J,? Podlech J,? Grzimek N K. Mouse models of cytomegalovirus latency:? overview[J]. J Clin Virol,? 2002,? 25( Suppl 2):? S23-S36. [14]Kloover J S,? van-den-Bogaard A E,? van-Dam J G,? et al. Persistent rat cytomegalovirus (RCMV) infection of the salivary glands contributes to the anti-RCMV humoral immune response[J]. Virus Res,? 2002,? 85(2):? 163-172. [15]Sullivan K E,? Mullen C A,? Blaese R M,? et al. A multiinstitutional survey of the Wiskott-Aldrich syndrome[J]. J Pediatr,? 1994,? 125(6 Pt 1):? 876-885. [16]Andreansky S,? Liu H,? Turner S,? et al. WASP- mice exhibit defective immune responses to influenza A virus,? Streptococcus pneumoniae,? and Mycobacterium bovis BCG[J]. Exp Hematol,? 2005,? 33(4):? 443-451. [17]Strom T S,? Turner S J,? Andreansky S,? et al. Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells[J]. Blood,? 2003,? 102(9):? 3108-3116.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133